We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.93B
AUM Growth
+$244M
Cap. Flow
+$17M
Cap. Flow %
0.43%
Top 10 Hldgs %
14.31%
Holding
1,432
New
108
Increased
538
Reduced
575
Closed
84

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$7.62M
2
BABA icon
Alibaba
BABA
+$7.25M
3
TDOC icon
Teladoc Health
TDOC
+$4.82M
4
TSN icon
Tyson Foods
TSN
+$4.64M
5
QCOM icon
Qualcomm
QCOM
+$3.85M

Sector Composition

Rank Sector Weight
1 Technology 13.34%
2 Healthcare 12.65%
3 Financials 11.21%
4 Industrials 9.34%
5 Consumer Discretionary 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFJ
1201
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.41B
$213K 0.01%
16,238
+54
+0.3% +$699
USA icon
1202
Liberty All-Star Equity Fund
USA
$1.79B
$213K 0.01%
31,319
-33,787
-52% -$225K
GGM
1203
DELISTED
GUGGENHEIM CREDIT ALLOCATION FUND
GGM
$212K 0.01%
9,640
-207
-2% -$4.59K
ANDV
1204
DELISTED
Andeavor
ANDV
$212K 0.01%
1,381
-1,055
-43% -$156K
GDO
1205
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.1M
$211K 0.01%
13,000
-800
-6% -$13.2K
TWOU
1206
DELISTED
2U Inc
TWOU
$211K 0.01%
94
+4
+4% +$9.89K
ARDC
1207
Are Dynamic Credit Allocation Fund
ARDC
$296M
$210K 0.01%
+13,500
New +$215K
NVCR icon
1208
NovoCure
NVCR
$1.77B
$210K 0.01%
+4,000
New +$159K
DSL
1209
DoubleLine Income Solutions Fund
DSL
$1.23B
$208K 0.01%
10,285
-31
-0.3% -$627
MBI icon
1210
MBIA
MBI
$274M
$206K 0.01%
19,300
MKSI icon
1211
MKS Inc
MKSI
$19.8B
$206K 0.01%
2,567
-1,312
-34% -$120K
MQT
1212
DELISTED
BlackRock MuniYield Quality Fund II
MQT
$206K 0.01%
17,550
+900
+5% +$10.8K
KERX
1213
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$206K 0.01%
60,683
CCJ icon
1214
Cameco
CCJ
$38.4B
$205K 0.01%
17,981
LRFC
1215
DELISTED
Logan Ridge Finance Corp
LRFC
$205K 0.01%
3,928
-267
-6% -$13.9K
NML
1216
Neuberger Energy Infrastructure and Income Fund Inc
NML
$583M
$205K 0.01%
23,559
-1,770
-7% -$15.9K
SJT
1217
San Juan Basin Royalty Trust
SJT
$120M
$205K 0.01%
41,334
GWPH
1218
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$205K 0.01%
+1,185
New +$171K
BTZ icon
1219
BlackRock Credit Allocation Income Trust
BTZ
$935M
$204K 0.01%
16,696
UGI icon
1220
UGI
UGI
$7.76B
$203K 0.01%
+3,650
New +$197K
IWV icon
1221
iShares Russell 3000 ETF
IWV
$19.5B
$202K 0.01%
+1,173
New +$199K
RACE icon
1222
Ferrari
RACE
$69.9B
$202K 0.01%
1,478
-3,695
-71% -$486K
RFG icon
1223
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$339M
$202K 0.01%
6,115
-200
-3% -$6.63K
TRN icon
1224
Trinity Industries
TRN
$2.73B
$202K 0.01%
+7,663
New +$201K
LGF.A
1225
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$202K 0.01%
+8,300
New +$196K

Similar funds

Oppenheimer & Co's Q3 2018 Portfolio in Review

As of Q3 2018, Oppenheimer & Co held 1,432 positions worth $3.93B, up 6.6% from $3.68B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2018 filing shows 108 new, 538 increased, 575 reduced and 84 closed positions. Its largest new stake was Invesco DB Commodity Index Tracking Fund: 113,354 shares worth $2.04M. The largest sale was A V Homes, Inc., an estimated $12.7M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q3 2018 buy was Invesco DB Commodity Index Tracking Fund: 113,354 shares worth $2.04M.
  • Oppenheimer & Co added most to Meta Platforms (Facebook) in Q3 2018, an estimated $7.62M increase.
  • Oppenheimer & Co's biggest Q3 2018 reduction was Wabtec, cutting an estimated $4.88M.
  • Oppenheimer & Co fully exited A V Homes, Inc. in Q3 2018, selling an estimated $12.7M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.93B portfolio in Q3 2018.
  • Oppenheimer & Co opened 108 new positions and closed 84 in Q3 2018.
  • Oppenheimer & Co's portfolio value rose 6.6% quarter-over-quarter to $3.93B.

Based on Oppenheimer & Co's 13F filing for Q3 2018, filed 26 Oct 2018.